Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.

FDA approval stamp in red | Image credit: chrisdorney - stock.adobe.com

FDA Approves First 2 Denosumab Biosimilars

By Laura Joszt, MA

March 5th 2024

Wyost and Jubbonti were approved as interchangeable biosimilars for Xgeva and Prolia; however, there is no launch date yet pending litigation with the maker of the reference products.

Standardized Total Knee Arthroplasty Pathway Improves Outcomes in Minority Patients

By Dietrich W. Riepen, MD
Daniel Gelvez, BA

Garen A. Collett, MD
Paul Nakonezny, PhD
Kenneth A. Estrera, MD
Michael H. Huo, MD

May 5th 2021

In a minority-predominant patient population, a standardized pathway for total knee arthroplasty was associated with improved outcomes with no change in postoperative complication rates.

Variation in Fracture Risk Estimation Among East Asian Women

By Joan C. Lo, MD
Shefali Nath, MD, MPH

Minal Patel, MD
Malini Chandra, MS, MBA
Betsy Yang, MD
Miranda Ritterman Weintraub, PhD, MPH
Bruce Ettinger, MD

March 10th 2021

Fracture prediction tools for East Asian individuals vary by country. In the United States, the US-Asian Fracture Risk Assessment Tool provides hip fracture probabilities that correspond to observed estimates.

Economic Burden of Osteoporotic Fractures: The Tip of the Iceberg?

By Hatice Bolek, MD
Ertugrul Cagri Bolek, MD, MSc

Mine Durusu Tanriover, MD

December 11th 2020

The economic burden of osteoporotic fractures may be much higher than estimated: just the tip of the iceberg. In this letter, we suggest that the cost of these fractures might be underestimated by considering only direct medical cost.

<1 2 3 4 5

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions